# Public Health Regulatory Systems Strengthening - U01 Clinical Trials Not Allowed

Source: https://welltoldgrants.com/grants/rfa-fd-24-015-public-health-regulatory-systems-strengthening-u01-clinical/  
Official notice: https://www.grants.gov/search-results-detail/351575

> Food and Drug Administration offered grants of up to $150,000 to the applicants described in the notice. It expected to make one award worth $150,000 in total. Applications closed on March 29, 2024.

| Field | Value |
|---|---|
| Opportunity number | RFA-FD-24-015 |
| Agency | Food and Drug Administration |
| Status | Forecast |
| Deadline | March 29, 2024 |
| Award ceiling | $150,000 |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $150,000 |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Only the following organization is eligible to apply:Eligible OrganizationsThe Organization for Economic Cooperation and Development (OECD)Foreign InstitutionsNon-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

## What the grant funds

The purpose of the Public Health Regulatory Systems Strengthening NOFO is to partner with the Organization for Economic Co-Operation and Development (OECD), primarily to address the growing threat of illicit trade in health products (drugs, vaccines, medical devices, food) through the development of a whole-of-governments approach that relies on targeted, risk based, and efficient data driven models. The data will be used to develop mitigation strategies and potential regulatory and enforcement solutions that address substandard, misleading, and falsified food and medical products sold both in informal markets and through legitimate channels and raise the profile and awareness of this issue within the global community. The proposed cooperative agreement will also include work on other FDA public health topics of interest, including, but not limited to, addressing mis- and dis-information; strengthening regulatory frameworks by advancing health equity; promoting the use of good regulatory practices to develop regulations that are efficient, transparent, modern, and based on science and risk principles; and enhancing patient engagements in product development and quality of care.

## Questions people ask

### Is RFA-FD-24-015 still open?

No. It closed on March 29, 2024. A newer notice is open: PAR-27-017, rolling or no fixed deadline.

### Who can apply for Public Health Regulatory Systems Strengthening - U01 Clinical Trials Not Allowed?

Food and Drug Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Public Health Regulatory Systems Strengthening - U01 Clinical Trials Not Allowed?

Closed March 29, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $150,000 each. About $150,000 in total for one award.

### Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.